Integrated Filing — IndAS

General information about company
Scrip Code	500940
NSE Symbol	FINPIPE
MSEI Symbol	NOTLISTED
ISIN	INE183A01024
Name of company	FINOLEX INDUSTRIES LIMITED
Type of company	Main Board
Class of security	Equity
Date of start of financial year	01-Apr-2024
Date of end of financial year	31-Mar-2025
Date of board meeting when results were approved	23-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange	16-May-2025
Description of presentation currency	INR (in Actuals)
Reporting Type	Quarterly
Reporting Quarter	Fourth quarter
Nature of report standalone or consolidated	Consolidated
Whether results are audited or unaudited for the quarter ended	Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended	Audited
Segment Reporting	Multi segment
Description of single segment
Start date and time of board meeting	23-May-2025   18:00:00
End date and time of board meeting	23-May-2025   20:10:00
Whether cash flow statement is applicable on company	Yes
Type of cash flow statement	Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification	Declaration of unmodified opinion

Financial Results Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Consolidated	Consolidated
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1	Income
	Revenue from operations	11718100000	41419700000
	Other income	645700000	2466300000
	Total income	12363800000	43886000000
2	Expenses
(a)	Cost of materials consumed	7271900000	26219500000
(b)	Purchases of stock-in-trade	60100000	286200000
(c)	Changes in inventories of finished goods, work-in-progress and stock-in-trade	346900000	254900000
(d)	Employee benefit expense	512500000	2222800000
(e)	Finance costs	61800000	296400000
(f)	Depreciation, depletion and amortisation expense	268900000	1067100000
(f)	Other Expenses
1	Other Expenses	1814000000	7678300000
	Total other expenses	1814000000	7678300000
	Total expenses	10336100000	38025200000
3	Total profit before exceptional items and tax	2027700000	5860800000
4	Exceptional items	0	4169900000
5	Total profit before tax	2027700000	10030700000
6	Tax expense
7	Current tax	476300000	2259100000
8	Deferred tax	109900000	173000000
9	Total tax expenses	586200000	2432100000
10	Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement	0	0
11	Net Profit Loss for the period from continuing operations	1441500000	7598600000
12	Profit (loss) from discontinued operations before tax	0	0
13	Tax expense of discontinued operations	0	0
14	Net profit (loss) from discontinued operation after tax	0	0
15	Share of profit (loss) of associates and joint ventures accounted for using equity method	204300000	401700000
16	Total profit (loss) for period	1645800000	8000300000
17	Other comprehensive income net of taxes	-5096900000	-1828400000
18	Total Comprehensive Income for the period	-3451100000	6171900000
19	Total profit or loss, attributable to
	Profit or loss, attributable to owners of parent	0	0
	Total profit or loss, attributable to non-controlling interests	0	0
20	Total Comprehensive income for the period attributable to
	Comprehensive income for the period attributable to owners of parent	0	0
	Total comprehensive income for the period attributable to owners of parent non-controlling interests	0	0
21	Details of equity share capital
	Paid-up equity share capital	1236700000	1236700000
	Face value of equity share capital	2	2
27	Details of debt securities
22	Reserves excluding revaluation reserve		59732000000
23	Earnings per share
i	Earnings per equity share for continuing operations
	Basic earnings (loss) per share from continuing operations	2.66	12.94
	Diluted earnings (loss) per share from continuing operations	2.66	12.94
ii	Earnings per equity share for discontinued operations
	Basic earnings (loss) per share from discontinued operations	0	0
	Diluted earnings (loss) per share from discontinued operations	0	0
ii	Earnings per equity share
	Basic earnings (loss) per share from continuing and discontinued operations	2.66	12.94
	Diluted earnings (loss) per share from continuing and discontinued operations	2.66	12.94
24	Debt equity ratio
25	Debt service coverage ratio
26	Interest service coverage ratio
27	Disclosure of notes on financial results		4tThe standalone and consolidated financial results of Finolex Industries Limited (the 'Holding Company') and its two associates for the quarter and year ended March 31, 2025 have been reviewed by the Audit Committee and approved by the Board of Directors at their respective meetings held on May 23, 2025. The above results as at and for the year ended March 31, 2025 have been audited by the statutory auditors of the Holding Company.tttttt n5tThese results have been prepared in accordance with the recognition and measurement principles laid down in the applicable Indian Accounting Standards prescribed under section 133 of the Companies Act, 2013 read with the Companies (Indian Accounting Standards) Rules, 2015 and other accounting principles generally accepted in India and is in accordance with the requirements of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended).tttttt n6tThe Board of Directors have recommended a final dividend of Rs. 2.00 (100%) per equity share of Rs. 2 each and a special dividend of Rs. 1.60 (80%) per equity share of Rs. 2 each, aggregating to nRs. 3.60 (180%) per equity share of Rs. 2 each for the year ended March 31, 2025. The dividend is subject to the approval of the shareholders in the ensuing Annual General Meeting of Finolex Industries Limited. ntttttt n7tExceptional item pertains to the net gain amounting Rs. 416.99 crore recorded by the Holding Company on completion of transfer of rights on leasehold land admeasuring approximately 25.27 acres situated at Chinchwad, Pune, along with structures.tttttt n8tThe figures for the quarter ended March 31, 2025 and March 31, 2024 are the balancing figures between the audited figures in respect of the full financial year and the published unaudited year to date figures upto the third quarter of the respective financial year.

Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio

Statement of Asset and Liabilities
Particulars		Year ended (dd-mm-yyyy)
Date of start of reporting period		01-Apr-2024
Date of end of reporting period		31-Mar-2025
Whether results are audited or unaudited		Audited
Nature of report standalone or consolidated		Consolidated
	Assets
1	Non-current assets
	Property, plant and equipment	9871000000
	Capital work-in-progress	731700000
	Investment property	0
	Goodwill	0
	Other intangible assets	213000000
	Intangible assets under development	0
	Biological assets other than bearer plants	0
	Investments accounted for using equity method	1661600000
	Non-current financial assets
	Non-current investments	25994300000
	Trade receivables, non-current	0
	Loans, non-current	100000
	Other non-current financial assets	272300000
	Total non-current financial assets	26266700000
	Deferred tax assets (net)	50800000
	Other non-current assets	266200000
	Total non-current assets	39061000000
2	Current assets
	Inventories	7824200000
	Current financial asset
	Current investments	21440500000
	Trade receivables, current	3792500000
	Cash and cash equivalents	443900000
	Bank balance other than cash and cash equivalents	809700000
	Loans, current	132700000
	Other current financial assets	6900000
	Total current financial assets	26626200000
	Current tax assets (net)	0
	Other current assets	307900000
	Total current assets	34758300000
3	Non-current assets classified as held for sale	0
4	Regulatory deferral account debit balances and related deferred tax Assets	0
	Total assets	73819300000
	Equity and liabilities
1	Equity
	Equity attributable to owners of parent
	Equity share capital	1236700000
	Other equity	59732000000
	Total equity attributable to owners of parent	60968700000
	Non controlling interest	0
	Total equity	60968700000
2	Liabilities
	Non-current liabilities
	Non-current financial liabilities
	Borrowings, non-current	0
	Trade payables, non-current
	(A) Total outstanding dues of micro enterprises and small enterprises	0
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	0
	Total Trade payable	0
	Other non-current financial liabilities	101700000
	Total non-current financial liabilities	101700000
	Provisions, non-current	171200000
	Deferred tax liabilities (net)	2391300000
	Deferred government grants, Non-current	409800000
	Other non-current liabilities	0
	Total non-current liabilities	3074000000
	Current liabilities
	Current financial liabilities
	Borrowings, current	2210800000
	Trade payables, current
	(A) Total outstanding dues of micro enterprises and small enterprises	106000000
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	4335600000
	Total Trade payable	4441600000
	Other current financial liabilities	2699500000
	Total current financial liabilities	9351900000
	Other current liabilities	199900000
	Provisions, current	98600000
	Current tax liabilities (Net)	0
	Deferred government grants, Current	126200000
	Total current liabilities	9776600000
3	Liabilities directly associated with assets in disposal group classified as held for sale	0
4	Regulatory deferral account credit balances and related deferred tax liability	0
	Total liabilities	12850600000
	Total equity and liabilites	73819300000
	Disclosure of notes on assets and liabilities

Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars		3 months/ 6 month ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period		01-Jan-2025	01-Apr-2024
Date of end of reporting period		31-Mar-2025	31-Mar-2025
Whether accounts are audited or unaudited		Audited	Audited
Nature of report standalone or consolidated		Consolidated	Consolidated
1	Segment Revenue (Income)
	(net sale/income from each segment should be disclosed)
1	PVC resin	3900000000	16600100000
2	PVC pipes and fittings	11684000000	41040500000
	Total Segment Revenue	15584000000	57640600000
	Less: Inter segment revenue	3865900000	3865900000
	Revenue from operations	11718100000	41419700000
2	Segment Result
	Profit (+) / Loss (-) before tax and interest from each segment
1	PVC resin	513200000	1955000000
2	PVC pipes and fittings	1076400000	2356300000
	Total Profit before tax	1589600000	4311300000
	i. Finance cost	61800000	61800000
	ii. Other Unallocable Expenditure net off Unallocable income	-704200000	-704200000
	Profit before tax	2232000000	10432400000
3	(Segment Asset - Segment Liabilities)
	Segment Asset
1	PVC resin	7179700000	7179700000
2	PVC pipes and fittings	15589000000	15589000000
	Total Segment Asset	22768700000	22768700000
	Un-allocable Assets	51050600000	51050600000
	Net Segment Asset	73819300000	73819300000
4	Segment Liabilities
	Segment Liabilities
1	PVC resin	2173200000	2173200000
2	PVC pipes and fittings	3785400000	3785400000
	Total Segment Liabilities	5958600000	5958600000
	Un-allocable Liabilities	6892000000	6892000000
	Net Segment Liabilities	12850600000	12850600000
	Disclosure of notes on segments

Other Comprehensive Income
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Consolidated	Consolidated
	Other comprehensive income [Abstract]
1	Amount of items that will not be reclassified to profit and loss
1	Re-measurement of defined benefit plans	15700000	-8000000
2	Fair Value changes in equity instruments through OCI	-5960800000	-1944900000
	Total Amount of items that will not be reclassified to profit and loss	-5945100000	-1952900000
2	Income tax relating to items that will not be reclassified to profit or loss	-848200000	-124500000
3	Amount of items that will be reclassified to profit and loss
	Total Amount of items that will be reclassified to profit and loss
4	Income tax relating to items that will be reclassified to profit or loss	0	0
5	Total Other comprehensive income	-5096900000	-1828400000

Cash flow statement, indirect
Particulars				Year ended (dd-mm-yyyy)
A	Date of start of reporting period			2024-04-01
B	Date of end of reporting period			2025-03-31
C	Whether results are audited or unaudited			Audited
D	Nature of report standalone or consolidated			Consolidated
Part I	Blue color marked fields are non-mandatory.
	Statement of cash flows
	Cash flows from used in operating activities
	Profit before tax			10030700000
	Adjustments for reconcile profit (loss)
	Adjustments for finance costs			296400000
	Adjustments for decrease (increase) in inventories			-543900000
	Adjustments for decrease (increase) in trade receivables, current			783800000
	Adjustments for decrease (increase) in trade receivables, non-current			0
	Adjustments for decrease (increase) in other current assets			533300000
	Adjustments for decrease (increase) in other non-current assets			0
	Adjustments for other financial assets, non-current			40300000
	Adjustments for other financial assets, current			49300000
	Adjustments for other bank balances			0
	Adjustments for increase (decrease) in trade payables, current			1587400000
	Adjustments for increase (decrease) in trade payables, non-current			0
	Adjustments for increase (decrease) in other current liabilities			-496600000
	Adjustments for increase (decrease) in other non-current liabilities			0
	Adjustments for depreciation and amortisation expense			1067100000
	Adjustments for impairment loss reversal of impairment loss recognised in profit or loss			0
	Adjustments for provisions, current			-14900000
	Adjustments for provisions, non-current			0
	Adjustments for other financial liabilities, current			-807600000
	Adjustments for other financial liabilities, non-current			0
	Adjustments for unrealised foreign exchange losses gains			-65000000
	Adjustments for dividend income			0
	Adjustments for interest income			0
	Adjustments for share-based payments			0
	Adjustments for fair value losses (gains)			-621100000
	Adjustments for undistributed profits of associates			0
	Other adjustments for which cash effects are investing or financing cash flow			-5017900000
	Other adjustments to reconcile profit (loss)			0
	Other adjustments for non-cash items			-43400000
	Share of profit and loss from partnership firm or association of persons or limited liability partnerships			0
	Total adjustments for reconcile profit (loss)			-3252800000
	Net cash flows from (used in) operations			6777900000
	Dividends received			-177700000
	Interest paid			0
	Interest received			-786100000
	Income taxes paid (refund)			1987300000
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) operating activities			3826800000
	Cash flows from used in investing activities
	Cash flows from losing control of subsidiaries or other businesses			0
	Cash flows used in obtaining control of subsidiaries or other businesses			0
	Other cash receipts from sales of equity or debt instruments of other entities			0
	Other cash payments to acquire equity or debt instruments of other entities			0
	Other cash receipts from sales of interests in joint ventures			0
	Other cash payments to acquire interests in joint ventures			0
	Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships			0
	Cash payment for investment in partnership firm or association of persons or limited liability partnerships			0
	Proceeds from sales of property, plant and equipment			4202300000
	Purchase of property, plant and equipment			1155000000
	Proceeds from sales of investment property			0
	Purchase of investment property			0
	Proceeds from sales of intangible assets			0
	Purchase of intangible assets			0
	Proceeds from sales of intangible assets under development			0
	Purchase of intangible assets under development			0
	Proceeds from sales of goodwill			0
	Purchase of goodwill			0
	Proceeds from biological assets other than bearer plants			0
	Purchase of biological assets other than bearer plants			0
	Proceeds from government grants			0
	Proceeds from sales of other long-term assets			0
	Purchase of other long-term assets			0
	Cash advances and loans made to other parties			0
	Cash receipts from repayment of advances and loans made to other parties			0
	Cash payments for future contracts, forward contracts, option contracts and swap contracts			0
	Cash receipts from future contracts, forward contracts, option contracts and swap contracts			0
	Dividends received			193900000
	Interest received			495900000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			-3653700000
	Net cash flows from (used in) investing activities	83400000
	Cash flows from used in financing activities
	Proceeds from changes in ownership interests in subsidiaries			0
	Payments from changes in ownership interests in subsidiaries			0
	Proceeds from issuing shares			0
	Proceeds from issuing other equity instruments			0
	Payments to acquire or redeem entity's shares			0
	Payments of other equity instruments			0
	Proceeds from exercise of stock options			0
	Proceeds from issuing debentures notes bonds etc			0
	Proceeds from borrowings			-1576100000
	Repayments of borrowings			0
	Payments of lease liabilities			53300000
	Dividends paid			1546000000
	Interest paid			312400000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) financing activities			-3487800000
	Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes			422400000
	Effect of exchange rate changes on cash and cash equivalents
	Effect of exchange rate changes on cash and cash equivalents			0
	Net increase (decrease) in cash and cash equivalents			422400000
	Cash and cash equivalents cash flow statement at beginning of period			21500000
	Cash and cash equivalents cash flow statement at end of period			443900000